| 翻訳と辞書 |
| James L. Vincent ： ウィキペディア英語版 |
James L. Vincent
James L. "Jim" Vincent was the Chairman and CEO of Biogen Idec from 1985 to 2002. He graduated from Duke University's Pratt School of Engineering in 1961 with a Bachelor of Science degree. He received an MBA from the Wharton School of Business at the University of Pennsylvania in 1963. He is currently a member of the Board of Directors of Alnylam Pharmaceuticals and Board of Trustees of Duke University. He has two children, Aimee Jamison and Christopher Vincent.〔http://www.nytimes.com/1997/10/12/style/weddings-aimee-vincent-jeremiah-jamison.html〕
Vincent is credited with decisions leading to the financial stability and success of Biogen in the late 1980s and early 1990s.〔http://www.strategy-business.com/press/16635507/18003〕〔http://media.www.whartonjournal.com/media/storage/paper201/news/2001/09/24/News/Alum-Of.The.Week.James.Vincent-99733.shtml〕
== Early career ==
Prior to working in the healthcare industry, Vincent held senior positions at Texas Instruments in Europe and Japan. He chose to leave TI, and then joined Abbott Laboratories, as the Founding President of its Human Diagnostics Division.〔http://www.fuqua.duke.edu/admin/extaff/news/publications/ex_sum2003.pdf〕 He rose to President and Chief Operating Officer of Abbott. He then became the President of Allied Health and Scientific Products.〔http://www.fuqua.duke.edu/admin/extaff/news/publications/ex_sum2003.pdf〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「James L. Vincent」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|